$3.65
-0.05-1.35%
At close: Aug 17, 5:00 PM EST
$3.46
-0.24-6.49%
Pre-Market: 7:00 AM EST
Nasus Pharma Ltd
NSRXAMEX
Earnings: H1 2026 Earnings were released on Mon Aug 17th, before the market open
Nasus Pharma Market Sentiment
Market sentiment signals for Nasus Pharma (NSRX): analyst consensus, short interest, options flow and insider activity.
Key Signals
Analyst Consensus— Market Outperform
Short Interest▲ 2.4% short float
Options Flow— N/A
Insider Activity— N/A
Analyst Consensus
Market Outperform
3 analysts
Options Flow (P/C)
—
Avg Consensus PT
$20
+468.5%
Highest Price Target
$22
+535.8%
Laidlaw & Co.
Lowest Price Target
$18
+420.2%
Citizens
Short Interest
2.4%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
Recent Analyst Actions
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Mar 26, 2026 | Citizens | Jason N. Butler— | +420.2% | $19 → $18 | Maintained | Market Outperform |
| Dec 18, 2025 | Citizens | Jason Butler— | +449.1% | $19 | Initiate | Market Outperform |
